Table 4.
Maximum daily intake of 2’‐FL and DFL from the proposed use of the NF in FS for infants
| Population group | Age (months) | Body weight( a ) (kg) | Use level of the NF (mg/day) | Intake of the NF (mg/kg bw per day)( b ) | Intake of 2’‐FL and DFL (mg/day)( c ) | Intake of 2’‐FL and DFL (mg/kg bw per day)( b ) |
|---|---|---|---|---|---|---|
| Infants | ≤ 6 | 5.8 | 1,600 | 276 | 1,300 (2’‐FL) | 224 (2’‐FL) |
| 180 (DFL) | 31 (DFL) | |||||
| > 6 | 8.8 | 1,200 | 136 | 970 (2’‐FL) | 110 (2’‐FL) | |
| 130 (DFL) | 15 (DFL) |
bw: body weight; 2’‐FL: 2’‐fucosyllactose; DFL: difucosyllactose; NF: novel food.
(a)
Default and average body weights for each population group are available in EFSA Scientific committee (2012).
(b)
Intake in ‘mg/kg bw per day’ are calculated by considering the use levels in ‘mg/day’ and default body weights.
(c)
The intake is estimated considering the average composition of the NF: 2’‐FL 81% and DFL 11% w/w DM (rounded figures).